⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VCYT News
Veracyte, Inc.
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025
businesswire.com
VCYT
VCYT
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test
businesswire.com
VCYT
VCYT